Home → Research News → Ask-the-Expert Conferences: Research News → June 2008: Updates from the 2008 ASCO Annual Meeting → Tests for risk of recurrence after 5 years?

Tests for risk of recurrence after 5 years?

Page last modified on: August 20, 2008

Question from Acky: Are there any new tests for patients diagnosed over 5 years ago to understand their risk of recurrence? What about new types of tests such as hormone responsiveness, or genetic tests? Could one use her or his original cell block for these or are there any blood tests or other types of test?: Answer —Generosa Grana, M.D., F.A.C.P.: There is currently no test available that can or should be used in someone who is 5 years out from their original diagnosis to assess future prognosis. As an example, Oncotype DX is used to assess prognosis and to determine treatment, but its utility is at time of diagnosis. Things such as circulating tumor cells and other novel approaches may play a role in the future, but not at this point. So the only thing that I recommend to my patients who are at the 5-year or further point of the disease is to continue with usual surveillance and to stay positive.

On Wednesday, June 18, 2008 our Ask-the-Expert Online Conference was called Updates from the 2008 ASCO Annual Meeting. Generosa Grana, M.D., F.A.C.P. and Carol Kaplan, M.D. answered your questions about the latest research advances on screening, treatment, side effects, and more.

The materials presented in these conferences do not necessarily reflect the views of breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.

A production of LiveWorld, Inc.
Copyright 2008. All rights reserved.

Email Updates

Stay informed about current research, online events, and more.

Meet the Experts

Generosa Grana, M.D., F.A.C.P. is the director of the Cooper Cancer Institute and heads the division of hematology/medical oncology at Cooper University Hospital.

Carol Kaplan, M.D. is an assistant professor of clinical medicine in the Rena Rowan Breast Center at the Hospital of the University of Pennsylvania. Her work revolves around the clinical care of breast cancer patients, as well as teaching medical students and house staff.

Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.

Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003

View Mobile Site